Bernard Wealth Management Corp. Altimmune, Inc. Transaction History
Bernard Wealth Management Corp.
- $205 Billion
- Q1 2025
A detailed history of Bernard Wealth Management Corp. transactions in Altimmune, Inc. stock. As of the latest transaction made, Bernard Wealth Management Corp. holds 15 shares of ALT stock, worth $81. This represents 0.0% of its overall portfolio holdings.
Number of Shares
15
Previous 15
-0.0%
Holding current value
$81
Previous $109,000
31.19%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding ALT
# of Institutions
213Shares Held
39.4MCall Options Held
1.93MPut Options Held
1.4M-
Black Rock Inc. New York, NY5.32MShares$28.9 Million0.0% of portfolio
-
Ameriprise Financial Inc Minneapolis, MN5.25MShares$28.5 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.43MShares$24.1 Million0.0% of portfolio
-
State Street Corp Boston, MA3.47MShares$18.8 Million0.0% of portfolio
-
Tang Capital Management LLC San Diego, CA2.75MShares$14.9 Million1.49% of portfolio
About Altimmune, Inc.
- Ticker ALT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 49,025,300
- Market Cap $266M
- Description
- Altimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for obesity and liver diseases. The company's lead product candidate, pemvidutide (proposed INN, formerly known as ALT-801), is a GLP-1/glucagon dual receptor agonist that is in Phase 1b trial for the treatment of obesity and non-alcoholic steatohepatit...